Charles River Laboratories International Inc
Change company Symbol lookup
Select an option...
CRL Charles River Laboratories International Inc
CPSI Computer Programs and Systems Inc
TKNO Alpha Teknova Inc
BTM Bitcoin Depot Inc
RC Ready Capital Corp
NEOV NeoVolta Inc
SCHL Scholastic Corp
SIDU Sidus Space Inc
MGY Magnolia Oil & Gas Corp
CWBR CohBar Inc
Go

Health Care : Life Sciences Tools & Services | Mid Cap Blend
Company profile

Charles River Laboratories International, Inc. is a full service, non-clinical contract research company. The Company provides research models required in research and development of new drugs, devices, and therapies. The Company operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment includes the research models, research model services, and research and cells solutions businesses. The DSA segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. The Manufacturing segment includes Microbial Solutions and Biologics Solutions (Biologics).

Closing Price
$199.62
Day's Change
1.47 (0.74%)
Bid
--
Ask
--
B/A Size
--
Day's High
202.72
Day's Low
192.40
Volume
(Above Average)
Volume:
765,036

10-day average volume:
691,278
765,036
  • Prev Close
    198.15
  • Today's Open
    196.07
  • Day's Range
    192.40-202.72
  • Avg Vol (10-day)
    691.3K
  • Last (time)
    7:00p ET 09/22/23
  • Last (size)
    6.0K
  • 52-Wk Range
    181.22 - 262.00
    LowHigh
  • (02/08/23 - 04/27/23)
    10.15%
  • 38.7%
  • Market Cap
    10.2B
  • Shares Outstanding
    51.3M
  • 9.42
  • 21.03x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.3
  • 99.14
  • (% of float 08/31/23)
    3.06

Latest News

September 22, 2023
1:01 pm ET
Accesswire
1:00 pm ET
Accesswire
September 21, 2023
2:34 pm ET
Accesswire
1:02 pm ET
Accesswire
1:02 pm ET
Accesswire
September 20, 2023
1:01 pm ET
Accesswire
8:30 am ET
BusinessWire
September 19, 2023
12:45 pm ET
Accesswire
September 15, 2023
7:36 am ET
Zacks
September 14, 2023
8:00 am ET
BusinessWire
September 11, 2023
8:00 am ET
BusinessWire
September 09, 2023
7:00 pm ET
Globe Newswire
September 08, 2023
10:30 am ET
Zacks
September 06, 2023
9:35 am ET
Zacks
8:26 am ET
Zacks
8:00 am ET
BusinessWire
August 25, 2023
9:33 am ET
Zacks
August 24, 2023
7:05 pm ET
Newsfile
8:00 am ET
BusinessWire
August 22, 2023
9:00 pm ET
BusinessWire
August 21, 2023
8:05 pm ET
PR Newswire
August 18, 2023
10:42 am ET
Globe Newswire
August 09, 2023
1:52 pm ET
Globe Newswire
10:12 am ET
Zacks
8:30 am ET
Zacks
7:15 am ET
Zacks
7:00 am ET
BusinessWire
August 08, 2023
12:07 pm ET
Globe Newswire
August 03, 2023
5:05 pm ET
Zacks
August 01, 2023
8:02 am ET
BusinessWire
July 31, 2023
2:55 pm ET
Globe Newswire
July 24, 2023
10:17 am ET
Globe Newswire
July 19, 2023
12:14 pm ET
Globe Newswire
8:00 am ET
BusinessWire
July 18, 2023
5:25 pm ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.